Multicentric Castleman's disease in a patient with HIV

International Journal of STD and AIDS

Volumn 17, Issue 1, 2006, Pages 63-64

  Fowler, A ^a   Collins, L ^a   De Ruiter, A ^a   Whittaker, S ^a   Kulasegaram, R ^a   Bradbeer, C ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chemotherapy; Human herpes virus 8; Multicentric Castleman's disease; Septicaemia

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; TUBERCULOSTATIC AGENT; VINCRISTINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; CONSENSUS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LYMPHOPROLIFERATIVE DISEASE; PATIENT; PRIORITY JOURNAL; SEPTICEMIA; SYMPTOM;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DOXORUBICIN; ETOPOSIDE; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; LIPOSOMES;

EID: 30944435211     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206775220522     Document Type: Article

References (5)

1. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcomaassociated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80
2. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998;128:657-62
3. Carrington PA, Anderson H, Harris M, Walsh SE, Houghton JB, Morgenstern GR. Autoimmune cytopenias in Castleman's disease. Am J Clin Pathol 1990;94:101-4
4. Loi S, Goldstein D, Clezy K, Milliken ST, Hoy J, Chipman M. Castleman's disease and HIV infection in Australia. HIV Med 2004;5:157-62
5. Scott D, Cabral L, Harrington WJ. Treatment of HIV-associated multicentric Castleman's disease with oral etoposide. Am J Hematol 2001;66:148-50